From: The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer
Group
Trial (n = 69)
Control (n = 36)
P
Before treatment ()
85.31 ± 6.07
86.69 ± 7.81
0.334
After treatment ()
89.00 ± 9.92
84.17 ± 8.84
0.028